Coordination Pharmaceuticals, Inc.
6 clinical trials · Sponsor
◉ Watch Coordination Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Phase I Study of RiMO-401 With Radiation in Advanced Tumors (NCT06182579) | Coordination Pharmaceuticals, Inc. | 2024-02-22 |
| Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer (NCT05838729) | Coordination Pharmaceuticals, Inc. | 2023-04-03 |
| Phase I Study of CPI-300 in Patients With Advanced Tumors (NCT04808453) | Coordination Pharmaceuticals, Inc. | 2021-06-15 |
| Study of CPI-200 in Patients With Advanced Tumors (NCT03953742) | Coordination Pharmaceuticals, Inc. | 2019-07-01 |
| Study of CPI-100 in Patients With Advanced Tumors (NCT03781362) | Coordination Pharmaceuticals, Inc. | 2018-12-21 |
| Phase I Study of RiMO-301 With Radiation in Advanced Tumors (NCT03444714) | Coordination Pharmaceuticals, Inc. | 2018-04-10 |
Track Coordination Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.